Login / Signup

Pharmacovigilance regulatory actions by national pharmacovigilance centers in Arab countries following COVID-19 pandemic.

Sameh A Al-ZubiediManal Mohammed YounusSara Al-KhalidiMagnus EkiloThamir M Alshammari
Published in: Expert opinion on drug safety (2022)
The findings highlight the differences in preparedness and performance of different national PV centers in participating Arab countries. Improving digital infrastructure among participating countries could serve as a useful tool to minimize the impact of the pandemic on PV activities.
Keyphrases
  • quality improvement
  • adverse drug
  • sars cov
  • public health
  • coronavirus disease
  • transcription factor
  • emergency department
  • electronic health record